Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia

The paper considers whether a current treatment option for rheumatoid arthritis with genetically engineered biological agents that selectively block the activity of individual proinflammatory mediators and cell surface antigens involved in autoimmune inflammation may be performed in Karelia, which c...

Full description

Bibliographic Details
Published in:Modern Rheumatology Journal
Main Author: Irina Mikhailovna Marusenko
Format: Article in Journal/Newspaper
Language:Russian
Published: IMA-PRESS LLC 2013
Subjects:
генно-инженерные биологические препараты
инфликсимаб
моноклональные антитела
ревматоидный артрит
ритуксимаб
фактор некроза опухоли α
Medicine
R
Republic of Karelia
Online Access:https://doi.org/10.14412/1996-7012-2013-2446
https://doaj.org/article/ffe47e33567e4b80842c0a3466d389b1
id ftdoajarticles:oai:doaj.org/article:ffe47e33567e4b80842c0a3466d389b1
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:ffe47e33567e4b80842c0a3466d389b1 2023-05-15T18:06:25+02:00 Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia Irina Mikhailovna Marusenko 2013-12-01T00:00:00Z https://doi.org/10.14412/1996-7012-2013-2446 https://doaj.org/article/ffe47e33567e4b80842c0a3466d389b1 RU rus IMA-PRESS LLC https://mrj.ima-press.net/mrj/article/view/534 https://doaj.org/toc/1996-7012 https://doaj.org/toc/2310-158X 1996-7012 2310-158X doi:10.14412/1996-7012-2013-2446 https://doaj.org/article/ffe47e33567e4b80842c0a3466d389b1 Современная ревматология, Vol 7, Iss 4, Pp 97-100 (2013) генно-инженерные биологические препараты инфликсимаб моноклональные антитела ревматоидный артрит ритуксимаб фактор некроза опухоли α Medicine R article 2013 ftdoajarticles https://doi.org/10.14412/1996-7012-2013-2446 2023-03-19T01:38:44Z The paper considers whether a current treatment option for rheumatoid arthritis with genetically engineered biological agents that selectively block the activity of individual proinflammatory mediators and cell surface antigens involved in autoimmune inflammation may be performed in Karelia, which can achieve control of the disease, retard its progression, and improve prognosis. Article in Journal/Newspaper Republic of Karelia Directory of Open Access Journals: DOAJ Articles Modern Rheumatology Journal 0 4 97
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language Russian
topic генно-инженерные биологические препараты
инфликсимаб
моноклональные антитела
ревматоидный артрит
ритуксимаб
фактор некроза опухоли α
Medicine
R
spellingShingle генно-инженерные биологические препараты
инфликсимаб
моноклональные антитела
ревматоидный артрит
ритуксимаб
фактор некроза опухоли α
Medicine
R
Irina Mikhailovna Marusenko
Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
topic_facet генно-инженерные биологические препараты
инфликсимаб
моноклональные антитела
ревматоидный артрит
ритуксимаб
фактор некроза опухоли α
Medicine
R
description The paper considers whether a current treatment option for rheumatoid arthritis with genetically engineered biological agents that selectively block the activity of individual proinflammatory mediators and cell surface antigens involved in autoimmune inflammation may be performed in Karelia, which can achieve control of the disease, retard its progression, and improve prognosis.
format Article in Journal/Newspaper
author Irina Mikhailovna Marusenko
author_facet Irina Mikhailovna Marusenko
author_sort Irina Mikhailovna Marusenko
title Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
title_short Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
title_full Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
title_fullStr Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
title_full_unstemmed Rheumatoid arthritis therapy with genetically engineered biological agents in the Republic of Karelia
title_sort rheumatoid arthritis therapy with genetically engineered biological agents in the republic of karelia
publisher IMA-PRESS LLC
publishDate 2013
url https://doi.org/10.14412/1996-7012-2013-2446
https://doaj.org/article/ffe47e33567e4b80842c0a3466d389b1
genre Republic of Karelia
genre_facet Republic of Karelia
op_source Современная ревматология, Vol 7, Iss 4, Pp 97-100 (2013)
op_relation https://mrj.ima-press.net/mrj/article/view/534
https://doaj.org/toc/1996-7012
https://doaj.org/toc/2310-158X
1996-7012
2310-158X
doi:10.14412/1996-7012-2013-2446
https://doaj.org/article/ffe47e33567e4b80842c0a3466d389b1
op_doi https://doi.org/10.14412/1996-7012-2013-2446
container_title Modern Rheumatology Journal
container_volume 0
container_issue 4
container_start_page 97
_version_ 1766178053831000064

Similar Items